Single Dose, Dose-Ranging and 28-Day Repeat-Dose Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Dimethandrolone Undecanoate (DMAU) in Healthy Men.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dimethylnandrolone undecanoate (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- Acronyms DMAUPhase1
Most Recent Events
- 02 Jul 2017 Biomarkers information updated
- 15 Jun 2013 Results presented at the 95th Annual Meeting of the Endocrine Society.
- 15 Jun 2013 Status changed from recruiting to completed.